May 30 (Reuters) – Ireland-based Jazz Pharmaceuticals Plc
is nearing a deal to buy Celator Pharmaceuticals Inc
for about $1.5 billion, the Wall Street Journal
reported.
The post Jazz Pharma nears deal to buy Celator for about $1.5 bln -WSJ appeared first on NASDAQ.